Intravitreal Ranibizumab for the Treatment of Irvine-Gass Syndrome

References

• Gass JD, Norton EW. Cystoid macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic study. Retina. 2003;23:646–661
   Google Scholar
• Irvine SR. A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol. 1953;36:599–619
   PubMed Web of Science ®Google Scholar
• Egger EG. The Irvine-Gass syndrome. Ophthalmologica. 1973;167:443–445
   Google Scholar
• Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998;96:557–634
   PubMedGoogle Scholar
• Arevalo JF, Garcia-Amaris RA, Roca JA, et al. Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group. J Cataract Refract Surg. 2007;33:2098–2105
   PubMed Web of Science ®Google Scholar
• Wittpenn JR, Silverstein S, Heier J, et al. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol. 2008;146:554–560
   PubMed Web of Science ®Google Scholar
• Metge P, Bonnefoy-Mandirac C, Chauvet G. Hemato-aqueous barrier and the Irvine-Gass syndrom. Bull Soc Ophtalmol Fr. 1983;83:145–148
   Google Scholar
• Yonekawa Y, Kim IK. Pseudophakic cystoid macular edema. Curr Opin Ophthalmol. 2012;23:26–32
   PubMed Web of Science ®Google Scholar
• Shelsta HN, Jampol LM. Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update. Retina. 2011;31:4–12
   PubMed Web of Science ®Google Scholar
• Demirel S, Batioğlu F, Özmert E. Intravitreal ranibizumab for the treatment of cystoid macular edema in Irvine-Gass syndrome. J Ocul Pharmacol Ther. 2012;28:636–639
   Google Scholar
• Conway MD, Canakis C, Livir-Rallatos C, et al. Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg. 2003;29:27–33
   PubMed Web of Science ®Google Scholar
• Koutsandrea C, Moschos MM, Brouzas D, et al. Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study. Retina. 2007;27:159–164
   PubMed Web of Science ®Google Scholar
• Brynskov T, Laugesen CS, Halborg J, et al. Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants. Clin Ophthalmol. 2013;7:1171–1174
   PubMedGoogle Scholar
• Meyer LM, Schönfeld CL. Cystoid macular edema after complicated cataract surgery resolved by an intravitreal dexamethasone 0.7-mg implant. Case Rep Ophthalmol. 2011;2:319–322
   Google Scholar
• Dutra Medeiros M, Navarro R, Garcia-Arumí J, et al. Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome. Invest Ophthalmol Vis Sci. 2013;54:3320–3324
   PubMed Web of Science ®Google Scholar
• Solomon LD. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group I. J Cataract Refract Surg. 1995;21:73–81
   PubMed Web of Science ®Google Scholar
• Ismail RA, Sallam A, Zambarakji HJ. Pseudophakic macular edema and oral acetazolamide: an optical coherence tomography measurable, dose-related response. Eur J Ophthalmol. 2008;18:1011–1013
   Google Scholar
• Lardenoye CW, van Schooneveld MJ, Frits Treffers W, et al. Grid laser photocoagulation for macular oedema in uveitis or the Irvine-Gass syndrome. Br J Ophthalmol. 1998;82:1013–1016
   PubMedGoogle Scholar
• Deuter CM, Gelisken F, Stübiger N, et al. Successful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three cases. Ocul Immunol Inflamm. 2011;19:216–218
   PubMed Web of Science ®Google Scholar
• Scarpa G. Bilateral cystoid macular edema after cataract surgery resolved by vitrectomy. Eur J Ophthalmol. 2011;21:677–679
   Web of Science ®Google Scholar
• Querques G, Iaculli C, Delle Noci N. Intravitreal pegaptanib sodium for Irvine-Gass syndrome. Eur J Ophthalmol. 2008;18:138–141
   Google Scholar
• Mason JO 3rd, Albert MA Jr, Vail R. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina. 2006;26:356–357
   PubMed Web of Science ®Google Scholar
• Díaz-Llopis M, Amselem L, Cervera E, et al. Intravitreal injection of bevacizumab for pseudophakic cystoid macular edema resistant to steroids. Arch Soc Esp Oftalmol. 2007;82:447–450
   Google Scholar
• Spitzer MS, Ziemssen F, Yoeruek E, et al. Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg. 2008;34:70–75
   Web of Science ®Google Scholar
• Barone A, Russo V, Prascina F, et al. Short-term safety and efficacy of intravitreal bevacizumab for pseudophakic cystoid macular edema. Retina. 2009;29:33–37
   Google Scholar
• Arevalo JF, Maia M, Garcia-Amaris RA, et al. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology. 2009;116:1481–1487
   PubMed Web of Science ®Google Scholar
• Dhoot DS, Kaiser PK. Ranibizumab for age-related macular degeneration. Expert Opin Biol Ther. 2012;12:371–381
   PubMed Web of Science ®Google Scholar
• Bandello F, Berchicci L, La Spina C, et al. Evidence for anti-VEGF treatment of diabetic macular edema. Ophthalmic Res. 2012;48:16–20
   Google Scholar
• Campochiaro PA. Anti-vascular endothelial growth factor treatment for retinal vein occlusions. Ophthalmologica. 2012;227:30–35
   Google Scholar
• Wang E, Chen Y. Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization secondary to pathologic myopia: systematic review and meta-analysis. Retina. 2013;33:1375–1392
   PubMed Web of Science ®Google Scholar
• Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol. 2002;47:203–218
   PubMed Web of Science ®Google Scholar
• Wolf EJ, Braunstein A, Shih C, et al. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac. J Cataract Refract Surg. 2007;33:1546–1549
   PubMed Web of Science ®Google Scholar